Private Equity
1 min read · 18 October 2018
5 min read · 18 October 2018
San Francisco-based Future Family, a provider of fertility care services, has raised $10 million in a Series A round of funding led by Aspect Ventures. Also participating in the round are iNovia Capital, BBG Ventures, LaunchCapital, Ulu Ventures and Portfolia's FemTech Fund. Future Family, which provides a monthly payment service for such fertility services as egg freezing, in vitro fertilization and concierge care, has now raised $14.2 million in total funding. As part of the latest round, Aspect Ventures Partner Lauren Kolodny will join the board.
1 min read · 18 October 2018
7 min read · 18 October 2018
Pennsylvania-based PhaseBio Pharmaceuticals, a developer of treatments for orphan diseases, has raised $46 million for its IPO after pricing its 9.2 million shares at $5 per share. The stock began trading October 18, 2018 on the NASDAQ under the ticker symbol "PHAS." Citigroup, Cowen and Stifel are the lead underwriters. PhaseBio's pre-IPO backers included New Enterprise Associates, Hatteras Venture Partners, Johnson & Johnson and Fletcher Spaght Ventures.
2 min read · 18 October 2018
3 min read · 18 October 2018
Synoste Ltd, a Finnish medical device company, has raised over 5 million euros in funding. The investors were Lifeline Ventures and AO Invest.
1 min read · 18 October 2018
3 min read · 18 October 2018
2 min read · 17 October 2018
French biotech firm Acticor Biotech has secured 15.3 million euros in Series B funding. Newton BioCapital led the round with participation from other investors that included Mirae Capital, CMS Medical Venture Investment Limited, A&B (HK) and CapDecisif Management.
1 min read · 17 October 2018